Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44])

The summary for the Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44]): This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and apply state-of-the-art multiplex assay technologies for measurement of multiple candidate biomarkers in small volumes of body fluid for musculoskeletal, rheumatic and skin diseases.
Federal Grant Title: Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-12-191
Type of Funding: Grant
CFDA Numbers: 93.846
CFDA Descriptions: Arthritis, Musculoskeletal and Skin Diseases Research
Current Application Deadline: Sep 07, 2015
Original Application Deadline: Sep 07, 2015
Posted Date: May 31, 2012
Creation Date: May 31, 2012
Archive Date: Oct 08, 2015
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 ...
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 ...
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...
Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa)
Niams Small Grant Program for New Investigators
Skin Diseases Research Core Centers
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com